	Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study. Front Immunol Li J, Ye Y, Cai Y, Ji H, Qin W, Luo Y, Zhou X, Zhang Z, Xiao X, Zhang B. PMID: 38736892 [PubMed - indexed for MEDLINE]
	A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma. BMC Cancer Pan Y, Chen Z, Hong W, Huang Z, Li Y, Cai S, Lai J, Lu J, Qiu S. PMID: 38734620 [PubMed - indexed for MEDLINE]
	The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis. Cancer Immunol Immunother Jin YN, Qiang MY, Wang Y, Lin YJ, Jiang RW, Cao WW, Zhang WJ, Wang SY, Zhang HY, Yao JJ. PMID: 38733402 [PubMed - indexed for MEDLINE]
	Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience. BMC Cancer Wu WB, Cai WL, Zou YH, You R, Liu YP, Yuan ZD, Li Q, Li WC, Pi ZX, Xie YL, Wen K, Chen MY, Sun R. PMID: 38730348 [PubMed - indexed for MEDLINE]
	Enhanced MRI Radiomics Based Model for Predicting Recurrence or Metastasis of Nasopharyngeal Cancer (NC) Undergoing Concurrent Chemoradiotherapy: A Retrospective Study. Cancer Control Song L, Liu J, Shang Y, Hu Y, Zhang J, Ye Y, Ji X, An P. PMID: 38716756 [PubMed - indexed for MEDLINE]
	Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma. Cancer Control Liu T, Li Y, Song J, Li B, Wang R, Huang T, Qin Y. PMID: 38716503 [PubMed - indexed for MEDLINE]
	Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma. BMC Immunol He Q, Luo X, Liu L, Zhao C, Li Z, Jin F. PMID: 38710996 [PubMed - indexed for MEDLINE]
	Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study. J Cancer Res Clin Oncol Song JM, Mo N, Lv YQ, Huang LL, Wen YJ, Liu T, Li ZR, Wang RS, Zhang TT. PMID: 38703186 [PubMed - indexed for MEDLINE]
	Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study. Sci Rep Yang D, Li P, Meng Z, Hu X, Huang Z, Huang H, Dong H, Qin Y, Chen C, Chen X, Li Z, Zhou Z, Li Y, Kang M. PMID: 38688967 [PubMed - indexed for MEDLINE]
	Could nutrition status predict fatigue one week before in patients with nasopharynx cancer undergoing radiotherapy? Cancer Med Song J, Yang X, Wu J, Wu Z, Zhuo L, Hong J, Su L, Lyu W, Ye J, Fang Y, Zhan Z, Zhang H, Li X. PMID: 38659395 [PubMed - indexed for MEDLINE]
	A bibliometric study of the nasopharyngeal cancer immunotherapy knowledge map. Medicine (Baltimore) Xie H, Liu W, Yang M. PMID: 38640273 [PubMed - indexed for MEDLINE]
	Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma. BMC Cancer Chen Y, Huang Y, Chen X, Chen Z, Peng X, Lin S, Lin C, Zong J. PMID: 38627711 [PubMed - indexed for MEDLINE]
	Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis. BMC Cancer Dong Z, Wang GY, Dai DY, Qin GJ, Tang LL, Xu C, Ma J. PMID: 38622555 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma - A Systematic Review and Meta-analysis. Oral Oncol Yeo BSY, Lee RS, Lim NE, Tan E, Jang IJH, Toh HC, Lim CM. PMID: 38615584 [PubMed - indexed for MEDLINE]
	Nomograms based on multiparametric MRI radiomics integrated with clinical-radiological features for predicting the response to induction chemotherapy in nasopharyngeal carcinoma. Eur J Radiol Chen Z, Wang Z, Liu S, Zhang S, Zhou Y, Zhang R, Yang W. PMID: 38613869 [PubMed - indexed for MEDLINE]
	Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study. Chronobiol Int Lin J, Lin X, Zheng R, Lin K, Khan M, Huang X, Tian Y, Wang B, Xu B, Yuan Y, Huang Z. PMID: 38606920 [PubMed - indexed for MEDLINE]
	A machine learning approach for predicting radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma undergoing tomotherapy. Sci Rep Quan KR, Lin WR, Hong JB, Lin YH, Chen KQ, Chen JH, Cheng PJ. PMID: 38600141 [PubMed - indexed for MEDLINE]
	Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma. BMC Cancer Cao X, Wang X, Song J, Su Y, Wang L, Yin Y. PMID: 38589858 [PubMed - indexed for MEDLINE]
	New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy. Front Immunol Chowaniec H, , Mroczek M, Borowczyk M, Braszka M, Dworacki G, Dobosz P, Wichtowski M. PMID: 38576614 [PubMed - indexed for MEDLINE]
	Impact of toll-like receptor 4 variations on nasopharyngeal carcinoma risk and survival in tunisian population. Tunis Med Ben Chaaben A, Ayadi I, Abaza H, Baroudi O, Douik H, Harzallah L, Bouassida J, Bouckouaci W, Guemira F, Mankai A, Kharrat M, Tamouza R. PMID: 38567476 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 8206

Page 1 of 411



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy